HOME STORY OF OUR FIRM SEARCH
ASBESTOS DRUGS POLLUTANTS ACCIDENTS MALPRACTICE
English En Français

FREE LEGAL REVIEW

First Name
Last Name
Home Phone
Work Phone
City and State
Email
Were you diagnosed with Asbestosis? Yes
No
Were you diagnosed with lung cancer? Yes
No
Were you diagnosed with Mesothelioma? yes
no
What is your date of diagnosis?
Additional Comments
Best time to call?

David N. Weissman, M.D.’s Testimony: dimensions of asbestos fibers

Read more from the testimony of Dr. Weissman, who spoke before the Senate’s Committee on the Environment and Public Works about the dangers of asbestos. In this section, he discusses the current dimensions of asbestos fibers.

Currently, a mineral particle is detected by PCM and counted as a fiber if it has a length to width (“aspect”) ratio of 3:1 and length of at least 5 micrometers.

These counting rules include particles with diameters greater than 3 microns, which are unlikely to reach the airways or the gas-exchange regions of the lungs when inhaled.

Also, PCM cannot detect particles with diameters less than about 0.25 micrometers, which, although not visible by PCM, are capable of causing harm.

Finally, although longer fibers have been associated with greater potential for carcinogenicity, studies of fibers deposited in human tissues suggest that fibers less than 5 micrometers in length may also contribute to human disease, including cancer.

The broad goals of the research outlined in the Roadmap are to: 1) provide a scientific framework for evidence-based worker protection recommendations; 2) address the broad range of mineral fibers to which workers are exposed; and 3) refine our understanding of fiber characteristics associated with toxicity.

Strategic goals identified by the Roadmap are to: 1) develop improved sampling and analytical methods for mineral fibers; 2) develop information and knowledge on occupational exposures to the range of mineral fiber types and their health outcomes; and 3) develop a broader understanding of the important determinants of fiber toxicity.

In particular, it would be useful to develop approaches that would make it possible to predict the ability of various mineral fiber types to cause human disease and apply this information for risk management.

NIOSH has solicited public comment on the draft Roadmap document via docket submissions and a public meeting.

The draft document was first made available to the public on February 28, 2007, and public comments were accepted into the docket from the time of posting until May 31, 2007. The public meeting was held on May 4, 2007.

Peer reviewers have been selected and are being provided with a copy of the public comments as well as the draft Roadmap document. Revision of the document will take into account both public and peer review comments. The goals expressed in the Roadmap are ambitious. NIOSH plans to develop a range of partnerships to address these goals, including with other Federal agencies, labor, industry, academia, and other interested parties.

Although NIOSH will focus on occupational safety and health, we will pursue opportunities to ensure that the results of research arising from the Roadmap can be extended outside of the occupational setting.

Courtesy of the U.S. Department of Health and Human Services (HHS): http://www.hhs.gov/asl/testify/2007/06/t20070612c.html

Courtesy of EPA

Other helpful links:

Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney

Mesothelioma Mesothelioma Home Page
head Mesothelioma: An Overview
kleio The Clock Is Ticking
asbestos Our Toughest Cases
head Diagnosis
treatment Symptoms, Stages, Treatment
kleio Latest News
New York Numbers
Asbestos


Mesothelioma
Asbestos
Asbestos Help
News & Warnings
Official Documents
IN THIS SECTION
Testimony from Dr. Weissman on asbestos
Mesothelioma: NIOSH
NIOSH’s Dr. Weissman on asbestos related disease
Dr. Weisman on rise in asbestos mortality rate
Dr. Weisman explains danger of asbestos exposure
limiting asbestos exposure
Dr. Weisman testimony on asbestos-caused disease
Dr. Weisman testimony on asbestos-related diseases
Dr. Weissman of NIOSH on institute’s asbestos aim
Dr. Weissman on asbestos cancers in Libby, MT
Dr. Weissman discusses dangers of asbestos fibers
Dr. Weissman on asbestos exposure assessment
Dr. Weissman on asbestos-related health research
Dr. Weissman talks on asbestos and mineral fibers
Dr. Weissman talks on asbestos and minerals
Dr. Weissman on asbestos fiber dimensions
Final comments by Dr. Weissman on asbestos dangers

For legal help anywhere in the U.S. call:

1 - 800 - 476 - 6070

Prior results do not guarantee a similar outcome.

ATTORNEY ADVERTISING

see also:

Dr. Weissman talks on asbestos and minerals Dr. Weissman testifies on minerals classified as containing asbestos
Dr. Weissman on regulatory definitions of asbestos-containing minerals

Dr. Weissman on asbestos fiber dimensions Dr. Weissman on asbestos fiber dimensions and carcinogenicity
Dr. Weissman on significance of asbestos fiber dimensions

NIOSH’s on asbestos health dangers NIOSH’s Dr. Weissman testifies on health dangers of asbestos exposure
Senate Committee testimony by Dr. Weissman on asbestos health dangers